These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 427785

  • 21. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
    Proctor JW, Stiteler RD, Yamamura Y, Mansell PW, Winters R.
    Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
    [Abstract] [Full Text] [Related]

  • 22. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N, Fisher B.
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract] [Full Text] [Related]

  • 23. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
    Kreider JW, Bartlett GL, Purnell DM.
    J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
    [Abstract] [Full Text] [Related]

  • 24. Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1982 Jun; 42(6):2211-5. PubMed ID: 7042079
    [Abstract] [Full Text] [Related]

  • 25. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
    Douple EB.
    Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
    [Abstract] [Full Text] [Related]

  • 26. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 27. Effect of prolonged Corynebacterium parvum and cyclophosphamide administration on spontaneously occurring metastases.
    Wolmark N, Fisher B.
    Surg Forum; 1975 Feb; 26():136-8. PubMed ID: 1216089
    [No Abstract] [Full Text] [Related]

  • 28. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M, Saito M, Abe S, Mizuno D.
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [Abstract] [Full Text] [Related]

  • 29. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG, Peters LC.
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA, Kleinerman J, Saidel GM.
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B, Gebhardt M, Linta J, Saffer E.
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB, Serrou B.
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [Abstract] [Full Text] [Related]

  • 33. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND, Kreider JW, Horetsky RL.
    Cancer Res; 1988 Feb 15; 48(4):943-9. PubMed ID: 2962735
    [Abstract] [Full Text] [Related]

  • 34. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I, Cohen D, Robinson E, Haber M, Weiss DW.
    Cancer Res; 1975 Jul 15; 35(7):1779-90. PubMed ID: 1093676
    [Abstract] [Full Text] [Related]

  • 35. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
    Chen WR, Liu H, Ritchey JW, Bartels KE, Lucroy MD, Nordquist RE.
    Cancer Res; 2002 Aug 01; 62(15):4295-9. PubMed ID: 12154032
    [Abstract] [Full Text] [Related]

  • 36. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV.
    Int J Cancer; 1974 Nov 15; 14(5):684-90. PubMed ID: 4459281
    [No Abstract] [Full Text] [Related]

  • 37. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV, Halpern BN.
    Cancer Res; 1974 Feb 15; 34(2):341-4. PubMed ID: 4810906
    [No Abstract] [Full Text] [Related]

  • 38. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS, Clark AW.
    Br J Surg; 1976 Feb 15; 63(2):152-3. PubMed ID: 766891
    [No Abstract] [Full Text] [Related]

  • 39. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE, Esber HJ, Taylor DJ, Gray JH.
    Cancer Res; 1974 Jul 15; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract] [Full Text] [Related]

  • 40. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C.
    Ojea A, Nogueira JL, Solsona E, Flores N, Gómez JM, Molina JR, Chantada V, Camacho JE, Piñeiro LM, Rodríguez RH, Isorna S, Blas M, Martínez-Piñeiro JA, Madero R, CUETO Group (Club Urológico Español De Tratamiento Oncológico).
    Eur Urol; 2007 Nov 15; 52(5):1398-406. PubMed ID: 17485161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.